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Phenolic profile and in vitro bioactive potential of
Saharan Juniperus phoenicea L. and Cotula
cinerea (Del) growing in Algeria
Dalila Ghouti, a,b Wahiba Rached, a,c,d Moussaoui Abdallah, e
Tânia C. S. P. Pires, a Ricardo C. Calhelha, a Maria José Alves, a
Lazzouni Hamadi Abderrahmane, f Lillian Barros *a and Isabel C. F. R. Ferreira *a
The aim of this study was to characterize the individual phenolic profile and antioxidant, anti-inflamma-
tory, cytotoxic, and antimicrobial activities of hydroethanolic and infusion extracts prepared from Algerian
Saharan Juniperus phoenicea L. and Cotula cinerea (Del). The phenolic profile was determined using a
liquid chromatograph coupled to a diode array detector and an electrospray ionization mass spectro-
meter (LC-DAD-ESI/MS). A total of thirteen and nine individual phenolic compounds were identified in
J. phoenicea and C. cinerea, respectively. 3-p-Coumaroylquinic acid, quercetin- and myricetin-O-pento-
side were the major compounds present in J. phoenicea; on the other hand, C. cinerea presented luteo-
lin-7-O-glucoside, luteolin-O-malonylhexoside, and 5-O-caffeoylquinic acid as the main molecules. In
general, all samples exhibited interesting antioxidant activity when compared to the standard Trolox, but
J. phoenicea extracts presented the highest bioactivity. Likewise, all the samples exhibited anti-inflamma-
tory activity; thus J. phoenicea hydroethanolic extracts showed the highest potential (88 ± 8 µg mL−1). In
addition, their cytotoxicity was evaluated towards a panel of four selected cell lines (HeLa, NCI-H460,
MCF-7 and HepG2), and all the extracts showed cytotoxic effects, with J. phoenicea extracts being the
most effective. The in vitro antimicrobial activity of the plant extracts was moderate, Gram-positive bac-
teria thus being more sensitive than the Gram-negative strains (MIC values between 5 and 20 mg mL−1).
The present work suggests that J. phoenicea and C. cinerea are sources of bioactive ingredients with
potential use in the food and pharmaceutical industries.
1. Introduction
Medicinal plants are recognized for their therapeutic effects
and biological characteristics, due to the presence of several
bioactive substances belonging to different molecule classes,
such as terpenoids, alkaloids, and phenolic compounds, like
flavonoids, tannins, coumarins and phenolic acids.1 These
biomolecules are widespread in different plant parts, such as
fruits, leaves, and seeds.2 Nowadays, there is an increasing
interest in the consumption of phytochemicals, like phenolic
compounds, due to their important health effects, which are
caused by their protective properties against a variety of path-
ologies mainly related with oxidative stress.3 Many authors
have reported the beneficial effects of polyphenols and men-
tioned that they present numerous bioactive properties, such
as antibacterial,4,5 antiviral, antifungal,6 cytotoxic,7 and anti-
inflammatory8,9 properties. These properties depend on their
specific chemical structures10 and much attention has been
paid to the extraction and isolation of polyphenols from herbs
having the ability to protect food and living systems from per-
oxidative damage.11
In order to search for effective natural bioactive com-
pounds, the current study selected two traditional medicinal
plants based on their ethno-pharmacological importance, for
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being applied as pharmaceutical and dietary supplements.
Among the medicinal plants, Juniperus phoenicea L. and Cotula
cinerea (Del) are Algerian Saharan herbs, harvested from south-
west of Algeria and known to possess biological properties.
J. phoenicea (Cupressaceae) is a small shrub of the
Mediterranean basin, mostly distributed in its western part
and largely growing in the Algerian mountains.12 J. phoenicea
is considered an important medicinal plant that is used in
folk medicine, where decoctions and infusions of its leaves are
used to treat diarrhea, rheumatism, bronco-pulmonary, diure-
tic, diabetic and obesity diseases;13,14 it is also used in the
treatment of hepatotoxicity and nephrotoxicity.15 A recent
study on J. phoenicea growing in Egypt reported that the crude
extracts (petroleum ether, chloroform, ethyl acetate, and
methanol) showed antiproliferative activity against lung carci-
noma (H460), liver tumor (HepG2), and breast carcinoma
(MCF7) cell lines.16 Moreover, the hydroethanolic extract pre-
pared from Algerian species demonstrated antioxidant
activity.17 The main bioactive compounds described in
Juniperus species are mostly phenolic compounds.18
Boulanouar et al.17 analyzed these molecules using spectro-
photometric methods and concluded that hydroalcoholic
extracts of the aerial parts of J. phoenicea mainly presented
phenolic acids and flavonoids. In addition, the presence of the
biflavone, agathisflavone, in hydroalcoholic extracts of
J. phoenicea leaves growing in Egypt was also reported.16 Four
flavonoid derivatives (cupressuflavone, hinokiflavone, hypolae-
tin-7-O-β-xylopyranoside and catechin) present in petroleum
ether, chloroform, and methanol fractions obtained from the
crude ethanol extract of the aerial parts of J. phoenicea growing
in Saudi Arabia were isolated and detected by Alqasoumi
et al.19
Cotula cinerea (Del) is a synonym of Brocchia cinerea (Dil.)
Vis. (Asteraceae); it is known as a xerophytic herb in Algeria by
the name “Guertouffa” or Saharan camomile (English) and is
commonly found in the Algerian desert.12 It is traditionally
used as infusions and decoctions to treat digestive troubles,
rheumatoid arthritis, urinary and pulmonary infections, fever,
headaches, migraines, coughs, and joint inflammation.20 This
species has been described to have antioxidant, analgesic,
antiseptic, and antimicrobial properties.21–24 The main com-
pounds have been isolated from the methanol extracts of
Egyptian and Moroccan C. cinerea, and identified as phenolic
acids (neochlorogenic acid, chlorogenic acid, cryptochloro-




glucoside, and 5,3′,4′-trihydroxy 3,6,7-trimethoxyflavone).25,26
In this study, the most common form of consumption
(infusion) of J. phoenicea and C. cinerea (Del) collected in
southwest of Algeria was compared with a crude hydroethano-
lic extract. The extracts of both species were characterized in
terms of phenolic composition and bioactive properties, such
as antioxidant, cytotoxic, anti-inflammatory, and antimicrobial
activities.
2. Materials and methods
2.1. Plant material
The samples of Juniperus phoenicea L. leaves and Cotula cinerea
(Del) aerial parts were collected in southwest of Algeria at EL
Bayadh (33° 05′ 18″ North; 0° 34′ 52″ East) and Bechar (31° 01′
00″ North; 2° 44′ 00″ West), respectively, during the flowering
period (May 2015). The plants were identified by Okacha
Hasnaoui, Professor at the University of Tlemcen, Algeria. The
samples were dried and ground to a fine powder (∼20 mesh)
prior to analysis.
2.2. Extraction procedure
Hydroethanolic and infusion extracts were prepared from
J. phenica leaves and C. cinerea aerial parts. The hydroethanolic
extraction (80% ethanol, 30 mL) was performed by maceration
(150 rpm), with 1 g of each sample at 25 °C for 1 h and then
filtered; the residue was re-extracted using the same method-
ology. Afterwards, the extracts were evaporated in order to
remove the ethanol, under reduced pressure (Büchi R-210
rotary evaporator, Flawil, Switzerland). For aqueous extracts,
2 g of plant material was infused with boiling distilled water
(200 mL) for 15 min and then filtered. Both extracts were pre-
viously frozen before lyophilizing (FreeZone 4.5, Labconco,
Kansas City, MO, USA), in order to obtain a dry extract.
The lyophilized hydroethanolic and infusion extracts were
dissolved in ethanol/water (80 : 20, v/v) and water, respectively,
to obtain a stock solution of 10 mg mL−1 for the antioxidant
activity assays: 5 mg mL−1 for the phenolic compound charac-
terization; 20 mg mL−1 in culture medium for the anti-
microbial assays; finally, 8 mg mL−1 in water for anti-inflam-
matory and cytotoxicity tests. In the bioactivity evaluation
assays, the stock solutions were further diluted and tested.
2.3. Phenolic compound characterization
LC-DAD-ESI/MSn (Dionex Ultimate 3000 UPLC, Thermo
Scientific, San Jose, CA, USA) was used for phenolic compound
characterization (identification and quantification), as pre-
viously detailed by Bessada et al.27 The detection was pre-
formed using a diode array detector (DAD, 280, 330, and
370 nm as the preferred wavelengths) and an ESI mass spectro-
meter operated in the negative mode (Linear Ion Trap LTQ XL
mass spectrometer, Thermo Finnigan, San Jose, CA, USA).
Calibration curves were prepared with different available stan-
dards and the results are expressed as mg per g of extract.
2.4. Antioxidant activity assays
Four different in vitro methods were used to evaluate the anti-
oxidant activity, DPPH radical-scavenging activity, reducing
power, β-carotene bleaching inhibition assay and lipid peroxi-
dation inhibition by TBARS using methodologies previously
described by Sobral et al.28 Results are expressed as EC50
values (μg mL−1) and Trolox was used as a positive control.
2.5. Anti-inflammatory activity assay
LPS-induced NO (nitric oxide) production by the murine
macrophage (RAW 264.7) cell line was determined using the
Food & Function Paper





















































nitrite concentration in the culture medium according to a
method previously described by Sobral et al.28 Results are
expressed as EC50 values (µg mL
−1), and dexamethasone was
used as a positive control.
2.6. Cytotoxicity assays
Cytotoxicity was evaluated against four human tumor cell
lines, MCF-7 (breast carcinoma), NCI-H460 (non-small cell
lung cancer), HeLa (cervical carcinoma), HepG2 (hepatocellu-
lar carcinoma), and non-tumor porcine liver cell line (PLP2),
using the sulphorhodamine assay previously described by
Sobral et al.28 Results are expressed as GI50 (µg mL
−1) and
Ellipticine was used as a positive control.
2.8. Antimicrobial activity assays
The antimicrobial activity of the samples was tested against a
range of strains from different microorganism: four Gram-
positive bacteria (MRSA – methicillin-resistant Staphylococcus
aureus, MSSA – methicillin-susceptible Staphylococcus aureus,
Listeria monocytogenes and Enterococcus faecalis) and five
Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae,
Proteus mirabilis, Morganella morganii and Pseudomonas aerugi-
nosa) and one yeast (Candida albicans). The minimal inhibitory
concentrations (MIC) were performed by the microdilution
method using the p-iodonitrotetrazolium chloride (INT) colori-
metric assay according to Dias et al.29 The minimal bacteri-
cidal concentration (MBC) and minimal fungicidal concen-
tration (MFC) were calculated by adding 10 µL of the MIC
value to fresh culture medium to see whether the bacteria were
able to grow. After 24 h of incubation at 37 °C, MBC and MFC
were registered. The antibiotic susceptibility profile of microor-
ganisms has previously been described.29
2.8. Statistical analysis
For each species, three samples were used and all the assays
were carried out in triplicate. Statistical comparisons were per-
formed using the SPSS Statistics v. 23.0 program (differences
were significant at the level of α = 0.05) by using one-way ana-
lysis of variance (ANOVA) followed by Tukey’s HSD. When
necessary, a Student’s t-test was used to determine the signifi-
cant differences between less than three different samples,
with p = 0.05. All the data were expressed as the mean values
with standard deviations (SD).
3. Results and discussion
3.1. Phenolic compound characterization
As shown in Tables 1 and 2, a total of thirteen and nine indi-
vidual phenolic compounds were identified in J. phoenicea and
C. cinerea, respectively. Nine flavonols, one biflavone, flavan-3-
ol, flavone, and a phenolic acid were identified in J. phoenicea;
on the other hand, four flavones, two flavonols, and three phe-
nolic acids were identified in C. cinerea.
Regarding J. phoenicea, peaks 2JP, 6JP and 9JP were positively
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characteristics by a comparison with commercial standards.
The remaining compounds were tentatively identified based
on their pseudomolecular ions and fragmentation pattern.
Flavonols were the most abundant flavonoids present in this
species, representing 51–57% of the phenolic composition,
with peaks 3JP, 4JP, 5JP, 7JP, and 8JP being identified as myrice-
tin glycosides based on their UV spectra (λmax around 356 nm)
and the production of a MS2 fragment ion at m/z 317.
Similarly, peaks 9JP, 10JP and 11JP were identified as quercetin
(λmax around 353 nm, MS
2 fragment at m/z 301) glycosides,
and peak 13 as isorhamnetin (λmax around 350 nm, MS
2 frag-
ment at m/z 315) glycoside. Peak 3JP ([M − H]− at m/z 611) was
identified as myricetin-O-pentosyl-O-hexoside, in which the
MS2 fragments revealed the alternative loss of pentosyl (m/z at
479; −132 u) and hexosyl (m/z at 317; −162 u) residues, indicat-
ing the location of each residue at different positions of the
aglycone. The remaining compounds presented MS2 fragments
corresponding to distinct losses of dihexosyl (−324 mu),
hexosyl (−162 mu), rhamnosyl (−146 mu), and pentosyl
(−132 mu) moieties. An elution order coherent with the type of
sugar substituent and according to their expected polarity was
presented, although the position and nature of the sugar moi-
eties could not be identified, because their retention times did
not correspond to any of the standards available. Peak 7 was
identified as myricetin-3-O-rhamnoside, which was previously
identified in berries and leaves of J. phoenicea by Ali et al.15
Peak 12 ([M − H]− at m/z 551) was identified as a methyl-
biflavonoid taking into account the findings of Innocenti
et al.30 and Miceli et al.,31 identifying this compound in fruits
of Juniperus communis. Peak 1 ([M − H]− at m/z 337) was identi-
fied as 3-p-coumaroylquinic acid taking into account the hier-
archical keys previously reported by Clifford et al.32 This was
the only phenolic acid present, and accounted for 43–49% of
the total phenolic compounds.
In general, 3-p-coumaroylquinic acid was the main phenolic
compound present in J. phoenicea, followed by quercetin-O-
pentoside and myricetin-O-pentoside. Moreover, the hydro-
ethanolic extract presented a higher concentration in these
than in the infusion extract.
The obtained individual profile was different from those
reported for the Egyptian J. phoenicea berries and leaves’
extracts, which revealed the presence of two major biflavonoid
compounds; cupressuflavone and amentoflavone in the ethyl
acetate fraction, four flavonoids (myricitrin, quercetin, cosmo-
sin, quercitrin), and two phenolic acids (p-coumaric acid and
caffeic acid) in the methanol fraction.15 The only compound
that was similar to the one identified in the present work was
myricitrin (peak 7). Moreover, Alqasoumi et al.19 studied
J. phoenicea petroleum ether, chloroform, and methanol frac-
tions from Saudi Arabia, resulting in the identification of five
known diterpenoids (13-epicupressic acid, imbricatolic acid,
7-α-hydroxysandaracopimaric acid, 3-β-hydroxysandaracopimaric
acid and isopimaric acid) and four flavonoid derivatives
(cupressuflavone, hinokiflavone, hypolaetin-7-O-β-xylopyranoside,
and (+)-catechin). Maamoun et al.16 identified 4 flavonoids
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agathisflavone) from ethanol, petroleum ether, chloroform,
ethyl acetate, and methanol extracts of J. phoenicea growing in
Egypt. These differences could be attributed to several factors
such as geographical location, the part of the plant used and
especially the use of different extraction methodologies and
solvents.
Concerning C. cinerea, phenolic acids were the minor group
of compounds present (22–28%), while flavonoids represented
72–78% of the phenolic composition. Peaks 1cc, 6cc and 8cc
were identified as 5-O-caffeoylquinic acid, 3,5-O-dicaffeoylqui-
nic acid, and 4,5-O-caffeoylquinic acid, respectively, according
to the hierarchical keys previously developed by Clifford et al.32
These compounds were also found in the areal parts of
Morocco C. cinerea methanol extracts.25 The remaining com-
pounds correspond to flavonoid derivatives, mainly luteolin
(λmax around 345 nm, MS
2 fragment at m/z 285) and quercetin
(λmax around 350 nm, MS
2 fragment at m/z 301) glycosides.
Peaks 2cc ([M − H]− at m/z 609), 3cc ([M − H]− at m/z 463), 4cc
([M − H]− at m/z 579), and 5cc ([M − H]− at m/z 447) were
identified as luteolin-dihexoside, quercetin-O-hexoside, luteo-
lin-O-pentosyl-hexoside, and luteolin-7-O-glucoside (identified
in comparison with a commercial standard), using a similar
reasoning as for the compounds described in J. phoenicea.
Furthermore, peaks 7 ([M − H]− at m/z 549) and 9 ([M − H]− at
m/z 533) released a MS2 fragment at m/z 301 and 285 ([M −
H − 162 − 86]−, loss of a malonylhexoside moiety), being tenta-
tively assigned quercetin and luteolin-O-malonylhexoside,
respectively.
Overall, luteolin-7-O-glucoside, luteolin-O-malonylhexoside,
and 5-O-caffeoylquinic acid were the main molecules present
in both infusion and hydroethanolic extracts obtained from
C. cinerea; thus the latter extracts revealed the highest concen-
tration in all the detected compounds.
Dendougui et al.33 studied the ethanolic extract of
C. cinerea from Algeria, revealing the presence of germacrano-
lide, tatridin A, and seventeen flavonoid derivatives, such as
luteolin, apigenin, and quercetin glycosides. Khallouki et al.25
studied Morocco C. cinerea methanol extracts, describing the
presence of phenolic acids (chlorogenic acid and dicaffeoylqui-
nic acid derivatives) and one flavonoid (luteolin-4′-O-gluco-
side), thus being very similar to the herein described phenolic
acid composition. Ahmed et al.26 reported different flavonoids
in this species, namely 7-O-β-D-diglucoside and 7-O-β-D-gluco-
side of luteolin, and luteolin itself, as well as apigenin-7-O-α-L-
rhamnoside. All of these described profiles present some simi-
larities to the ones presented herein. Thus, the variances in
the chemical composition could also be due to the same
factors mentioned above for the precedent species, including
different types of extraction methodologies, the nature of the
solvents used, the bioclimatic zone divergence and the plant
parts used to obtain the extracts.
3.2. Antioxidant activity
The results on the antioxidant activity of both J. phoenicea and
C. cinerea hydroethanolic and infusion extracts are shown in
Table 3. For a broader evaluation of the antioxidant capacity,
four assays were carried out: DPPH radical scavenging activity,
reducing power, β-carotene bleaching inhibition and lipid per-
oxidation inhibition in brain cell homogenates (TBARS). The
results were compared with the standard Trolox and expressed
as EC50 values. Based on these results, J. phoenicea and
C. cinerea extracts showed interesting antioxidant properties,
particularly for the TBARS assays, in which all samples were
demonstrated to be two to three times more effective than
Trolox, with EC50 values of 7.6 ± 0.3 and 7.4 ± 0.3 µg mL
−1 for
hydroethanolic extracts and EC50 of 6.7 ± 0.2 and 7.5 ± 0.2
µg mL−1 for infusion extracts of J. phoenicea and C. cinerea,
respectively. These extracts showed anti-lipid peroxidation pro-
prieties, which are of great interest in food preservation.11 The
scavenging activity evaluated by the DPPH assay showed that
J. phoenicea presented very low EC50 values for both extracts
(12 ± 1 and 22.4 ± 0.6 µg mL−1 for hydroethanolic and infusion
extracts, respectively), indicating a strong ability to donate
hydrogen and scavenge the free DPPH radical, probably due to
Table 3 Antioxidant activity and NO production inhibition capacity of J. phoenicae and C. cinerea extracts (mean ± SD)











Antioxidant activity (EC50 values, µg mL
−1)
DPPH scavenging activity 12 ± 1d 22.4 ± 0.6c 26.0 ± 0.1a 24.8 ± 0.2b 42 ± 1
Reducing power 12.0 ± 0.4d 18.2 ± 0.3c 31.9 ± 0.2b 38 ± 1a 41 ± 1
β-Carotene bleaching
inhibition
11.57 ± 0.08c 20 ± 1a 14.7 ± 0.2b 20.2 ± 0.8a 18 ± 1
TBARS inhibition 7.6 ± 0.3a 6.7 ± 0.2b 7.4 ± 0.3a 7.5 ± 0.2a 23 ± 1
Anti-inflammatory activity (EC50 values, µg mL
−1)
Nitric oxide (NO) production 51 ± 4d 70 ± 5c 105 ± 9b 122 ± 6a 16 ± 1
a Trolox and dexamethasone for antioxidant and anti-inflammatory activities, respectively. The antioxidant activity was expressed as EC50 values
(mean ± SD), which means that higher values correspond to lower reducing power or antioxidant potential. EC50: extract concentration corres-
ponding to 50% of antioxidant activity or 0.5 absorbance in the reducing power assay. Results of anti-inflammatory activity are expressed as EC50
values: the sample concentration providing 50% of inhibition of nitric oxide (NO) production. In each row different letters mean significant
differences between extracts (p < 0.05).
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its phenolic composition. The results obtained were higher
than the ones reported by El Jemli et al.34 and Keskes et al.,14
who evaluated the ability of a Morrocan J. phoenicea water
extract for the scavenging activity of DPPH (EC50 = 30.7 ±
0.1 µg mL−1), and also Tunisien J. phoenicea ethyl acetate
extract (EC50 = 220 µg mL
−1) and hexane extract, which did not
show activity using this method. Nevertheless, Keskes et al.14
reported the methanol extract to show a stronger ability to sca-
venge DPPH radicals (EC50 value = 2 μg mL−1). Taviano et al.35
studied the antioxidant activity of methanol and water extracts
of five different Turkish Juniperus species, which showed a
weaker activity in comparison with the herein studied extracts.
On the other hand, the C. cinerea infusion extract demon-
strated a higher DPPH radical scavenging activity (EC50 =
24.8 ± 0.2 µg mL−1) in comparison with its hydroethanolic extract
(EC50 = 26.0 ± 0.1 µg mL
−1), contrary to what happened for all
the remaining methods for both species. Moreover, the activi-
ties of all the samples were higher than the ones displayed by
the commercial standard Trolox (EC50 = 42 ± 1 µg mL
−1).
These data are in accordance with the results obtained by
Khallouki et al.,25 who also reported a strong antioxidant
capacity (DPPH and FRAP assays) of the methanol extract from
Moroccan C. cinerea, and correlated this activity with its sig-
nificant content in echinoids and flavonoids. In fact, both
extracts from the two plant species revealed a relevant reducing
power, which increased with the increase of the extract concen-
tration, ranging from 12.04 ± 0.4 to 38.1 ± 1 µg mL−1, being
more effective than Trolox (41 ± 1 µg mL−1). Once more,
J. phoenicea hydroethanolic and infusion extracts exhibited the
best ability to reduce Fe3+ to Fe2+ (Table 3). The susceptibility
of an antioxidant capable of neutralizing free radicals and
inhibiting lipid peroxidation can be evaluated through a
β-carotene bleaching inhibition assay. For this methodology,
the hydroethanolic extracts of J. phoenicea and C. cinerea
demonstrated the highest activity (EC50 values of 11.57 ± 0.08
and 14.7 ± 0.2 µg mL−1, respectively), revealing a higher activity
than Trolox (EC50 values = 18.0 ± 1 µg mL
−1), while the infu-
sion extract of both plants showed lower or closer activity in
comparison with the commercial standard. The effectiveness
of the hydroethanolic extracts can be explained by their higher
concentration in phenolic compounds, which could influence
their capacity to scavenge free radicals and prevent lipid
peroxidation.36
3.3. Anti-inflammatory activity
The anti-inflammatory effect was evaluated using murine
macrophage-like RAW 264.7 cells and quantified through the
nitric oxide (NO) production, and the results are summarized
in Table 3. All the samples revealed inhibition of NO pro-
duction with EC50 values ranging between 51 ± 4 and 122 ±
6 µg mL−1. It can be noticed that the highest activity was
shown by both extracts of J. phoenicea (hydroethanolic and
infusion, with EC50 values of 51 ± 4 and 70 ± 5 µg mL
−1,
respectively). This activity could be attributed to the high
content of 3-p-coumaroylquinic acid and the flavonol deriva-
tives found in this species. The obtained results are also in
agreement with those reported by Jeong et al.,37 who found a
powerful anti-inflammatory activity in a Korean Juniper rigida
methanolic extract and its fractions (n-hexane, chloroform,
ethyl acetate and n-butanol). This ability was attributed to the
phenolic composition present in the extract, especially the
presence of phenylpropanoid glycosides, with p-hydroxy
groups, massoniaside A, (+)-catechin, and amentoflavone,
which effectively inhibited LPS-induced NO production in
RAW264.7 cells.37 Otherwise, C. cinerea hydroethanolic and
infusion extracts revealed lower inhibition of NO production,
with EC50 values of 105 ± 9 and 122 ± 6 µg mL
−1, respectively.
The activity observed for both extracts of C. cinerea could be
attributed to the presence of phenolic compounds, such as
luteolin-7-O-glucoside, luteolin-O-malonylhexoside, and 5-O-
caffeoylquinic acid. These findings could be associated with
the important usage of this species in traditional African medi-
cine.25,33 To the best of our knowledge, this is the first report
on the anti-inflammatory potential of J. phoenicea leaves and
C. cinerea areal parts.
3.4. Cytotoxic effects
The results on the antiproliferative effects of J. phoenicea and
C. cinerea hydroethanolic and infusion extracts are summar-
ized in Table 4. All the tested samples presented significant
Table 4 Cytotoxic properties of J. phoenicae and C. cinerea extracts in human tumor cell lines and non-tumor liver primary cells (mean ± SD)









Human tumor cell lines (GI50 values, µg mL
−1)
MCF-7 (breast carcinoma) 11 ± 1d 19 ± 1c 53 ± 4b 77 ± 6a 0.91 ± 0.04
NCI-H460 (non-small cell lung cancer) 30 ± 1c 51 ± 3b 50 ± 3b 101 ± 10a 1.03 ± 0.09
HeLa (cervical carcinoma) 9 ± 1d 17 ± 2c 47 ± 5b 51 ± 4a 1.91 ± 0.06
HepG2 (hepatocellular carcinoma) 15 ± 1d 22.4 ± 0.7c 31 ± 2b 42 ± 4a 1.1 ± 0.2
Non-tumor cells (GI50 values, µg mL
−1)
PLP2 (porcine liver primary cells) 88 ± 8d 137 ± 12b 120 ± 8c 198 ± 5a 3.2 ± 0.7
GI50 values (mean ± SD) correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver
primary culture PLP2. In each row different letters mean significant differences between extracts (p < 0.05).
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cytotoxic properties for the four human tumor cell lines tested
(MCF-7, NCI-H460, HeLa and HepG2), with GI50 values
ranging from 9 ± 1 to 101 ± 10 µg mL−1. Furthermore, the
samples also presented cytotoxic effects against non-tumor
cells (PLP2 – porcine liver primary cells); thus the GI50 values
were much higher than those needed to exert antiproliferative
activity in tumor cells and also much higher than those exhibi-
ted by the standard Ellipticine. J. phoenicea hydroethanolic
and infusion extracts demonstrated a higher cytotoxic poten-
tial in comparison with C. cinerea. The obtained results are
also in agreement with those reported by Maamoun et al.,16
who found higher activity against lung carcinoma (H460), liver
tumor (HepG2), and breast carcinoma (MCF7) cell lines with
the crude extract of Egyptian J. phoenicea leaves. Consecutively,
these authors screened the flavonoid agathisflavone, which
recorded higher cytotoxicity in the lung carcinoma (H460).16
Additionally, a significant in vivo hepatoprotective effect was
reported for J. phoenicea leaves.15,38 Tavares et al.39 also proved
the neuroprotective potential of the phenolic fractions
obtained from Portuguese J. phoenicea and other species of
Juniperus, attributing this capacity to the biflavones detected,
especially to amentoflavone. Furthermore, J. phoenicea is well
known to contain lignans, which are recognized for their inter-
esting antiproliferative and antiviral activities.40 Many reports
supposed that Juniperus species could be a source of bioactive
compounds with potential anti-cancer effects.41
On the other hand, C. cinerea hydroethanolic and infusion
extracts also presented antiproliferative activity, being more
active in the following order: HepG2 (31 ± 2 and 42 ± 4
µg mL−1), HeLa (47 ± 5 and 51 ± 4 µg mL−1), NCI-H460 (50 ± 3
and 101 ± 10 µg mL−1) and MCF-7 (53 ± 4 and 77 ± 6 µg mL−1).
In fact, the cytotoxicity of C. cinerea extracts was lower than the
one observed for J. phoenicea hydroethanolic and infusion
extracts; these differences could be due to the distinct individ-
ual phenolic profiles of both extracts. It has been previously
highlighted that some phenolic compounds can contribute to
protection against cancer disease, for example, p-coumaroyl-
quinic acid, quercetin, and myricetin derivatives, which were
the major phenolic compounds found in J. phoenica. These
compounds have exhibited a protective role for in vivo hepato-
toxicity and nephrotoxicity.15 To the best of our knowledge
there are no previous reports on the cytotoxic activity of
C. cinerea.
3.5. Antimicrobial activity
The antimicrobial activity results of both J. phoenicea and
C. cinerea extracts (hydroethanolic and infusion) tested against
ten pathogenic strains, and expressed as the minimal inhibi-
tory concentrations (MIC), minimal bactericidal concen-
trations (MBC) and minimal fungicidal concentrations (MFC),
are presented in Table 5. Overall, the extracts obtained from
both species were found to have moderate to weak activity,
with a higher effectiveness towards Gram-positive bacteria, in
comparison with Gram-negative. MIC values ranged between 5
and 20 mg mL−1, and the inhibitory effect tested against all
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The strains MRSA and MSSA were demonstrated to be more
susceptible to both J. phoenicea (MIC = 5 and 10 mg mL−1,
respectively) and C. cinerea (MIC = 10 and 5 mg mL−1, respect-
ively) extracts. On the other hand, Morganella morganii also
showed susceptibility towards J. phoenicea extracts revealing
MICs and MBCs values of 10 and 20 mg mL−1, respectively.
Regarding Gram-negative bacteria, J. phoenicea and C. cinerea
only presented inhibitory activity for Escherichia coli (MIC =
10 mg mL−1) and Klebsiella pneumonia (MIC and MBC = 20
mg mL−1). It is important to highlight that both J. phoenicea
extracts had the same behavior on all the bacteria tested, while
C. cinerea presented variation in the used extracts, especially
for the strains E. faecalis and MSSA. Regarding the yeast
Candida albicans, the extracts did not express any activity up to
the maximal tested concentration.
The antimicrobial activity of the J. phoenicea extract is sup-
ported by studies performed by Hammami et al.,42 who
demonstrated moderate to good activity of a Tunisian
J. phoenicea aqueous extract, obtained from seeds, and its frac-
tions (methanol and acetone), against Gram-positive (Listeria
monocytogenes, Listeria innocua, and Listeria ivanovii) and
Gram-negative (Escherichia coli and Pseudomonas aeruginosa)
bacteria. In a similar order, Alzand et al.43 proved significant
growth inhibition of Escherichia coli, Staphylococcus aureus,
and Klebsiella pneumonia using alcoholic extracts of
J. phoenicea barks from India. In contrast, Miceli et al.31
described the antibacterial activity of different species of
Turkish Juniperus ( J. communis L. var. communis and
J. communis L. var. saxatilis. Pall) methanol extracts, which
showed moderate capacity only against Gram-positive bacteria.
It should also be highlighted that the part of the plant used
and the phenolic compound concentration will also have a
great influence on the antibacterial activity obtained for each
extract. Thus, the antimicrobial activity obtained for both
extracts of J. phoenicea could also be related to the presence of
phenolic compounds, such as quercetin derivatives and p-cou-
maroylquinic acid, which are recognized for their anti-
microbial actions,4,44 supporting the antibacterial effectiveness
of the studied species.
Concerning C. cinerea antibacterial activity, it is in agree-
ment with the results described by Bensizerara et al.,23 who
evaluated the antibacterial properties of extracts obtained from
C. cinerea aerial parts using different polarity solvents
(ethanol, n-butanol, ethyl acetate and petroleum ether). These
authors revealed weak activity for all the mentioned extracts;
thus the most active fraction was n-butanol. Additionally,
Markouk et al.22 reported that the n-butanol extract obtained
from the Moroccan C. cinerea was highly effective
against germs in the tested concentrations (ranging from 12 to
200 µg mL−1). Nevertheless, the inhibition ability of the
bacterial growth shown by C. cinerea could also be associated
with important levels of flavonoids, such as quercetin and
luteolin derivatives, as was reported by Dendougui et al.33 and
Ahmed et al.26
Overall, the wide range of bioactive properties (antioxidant,
anti-inflammatory, cytotoxic and antibacterial) shown by the
hydroethanolic and infusion extracts of the studied Saharan
plants supports their traditional use as a popular remedy in
the treatment of cancer, infectious and inflammatory diseases.
These properties may be related to the presence of different
phenolic compounds at variable contents. Thus, further
studies are needed to establish the mechanisms of action, sup-
porting the use of these plants in the pharmaceutical and food
fields.
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